Lymphoma is one of the most common haematological cancers in adults, with an incidence of around 15 new cases per 100,000 inhabitants annually. “We are experiencing a true revolution in lymphoma treatments,” says Dr. Hernández. “Increasingly, we are seeking personalized therapies not only based on the tumour but also on the characteristics and preferences of our patients. Global survival ratesThe data supports this progress: the global survival rate for lymphoma patients has doubled in the last 30 years. Among its centres are the Hospital Universitario Fundación Jiménez Díaz, Centro Médico Teknon, Ruber Internacional, Hospital Universitario Quirónsalud Madrid, Hospital Quirónsalud Barcelona, Hospital Universitari Dexeus, Policlínica Gipuzkoa, Hospital Universitari General de Catalunya, Hospital Quirónsalud Sagrado Corazón, etc.